close

Se connecter

Se connecter avec OpenID

12th Thoracic Oncology Winter Symposium - BVP

IntégréTéléchargement
12th Thoracic Oncology
Winter Symposium
General information
Date
Saturday, 16 January 2016
Venue
Congress center ‘t Pand
Onderbergen 1
9000 Gent
Accreditation
Accredited with RIZIV/INAMI is pending, last year 3.5 E&E points
Accreditation application NVALT is pending
Target audience
This symposium will be of special interest for pulmonologists,
radiation oncologists, thoracic surgeons, medical oncologists,
pathologists, and investigators interested in thoracic oncology.
Registration
Please register on-line via the congress calendar on www.congresscare.com.
Registration fee is EUR 50 (EUR 30 for ASO’s), and is including admission to
the meeting, program/abstract book, break, lunch buffet and certificate of
attendance.
Delegates registering before Thursday, 14 January 2016 will receive a
confirmation e-mail with route description.
Cancellation
Written cancellations received before Tuesday, 5 January 2016 will be
refunded less EUR 15 administration costs.
Secretariat
Congress Care
Postbus 440
5201 AK ‘s-Hertogenbosch
The Netherlands
Tel +31 73 690 14 15
info@congresscare.com
www.congresscare.com
Saturday 16 January 2016 | ‘t Pand, Ghent
Introduction
Programme 16 January 2016
We are delighted to invite you to the 12th Thoracic Oncology Winter
Symposium on January 16, 2016.
09.00 Registration with coffee & croissants
This annual symposium offers a unique opportunity to meet (inter)
national experts in thoracic oncology. During the meeting exciting
innovations e.g immunotherapy and challenging controversies
(surgery in mesothelioma, surgery or SABR in early stage NSCLC...)
will be discussed.
09.35 Session 1: quality in lung cancer care
Chair: Annelies Janssens, UZA - Paul Baas, NKI Amsterdam, NL
Don’t miss the experience of this great meeting in the magnificent
city of Ghent...
We look forward to meet you in Ghent,
Prof. Dr. Jan Van Meerbeeck
Coördinator Thoraxoncologie
MOCA UZA
Prof. Dr. Veerle Surmont
Coördinator LONG
Ghent
09.30 Welcome - Veerle Surmont, UGent 09.35
Quality control and assessment in molecular pathology
Jo Van Dorpe, UGent
10.00
Integrating outcome and toxicity in clinical benefit
Martijn Kerst, NKI, Amsterdam, NL
10.25 Session 2: optimal treatment in stage I NSCLC Chair: Yolande Lievens, UGent - Michèle De Waele, UZA
10.25
SAB Radiotherapy
Umberto Ricardi, Torino University, I
10.45
VATS-resection
Rick Paul, VUMC, Amsterdam, NL
11.05
Interactive vote
Thomas Malfait, UGent
11.15 Coffee break
11.45 Session 3: controversies in thoracic oncology
Chair: Birgitta Hiddinga, UZA - Frank Vermassen, UGent
11.45
Immunotherapy: is more better?
Karim Vermaelen, UGent
12.10
Anti-angiogenesis in mesothelioma: more than untargeted therapy?
Arnauld Scherpereel, CHRU Lille, F
12.35
Surgery and mesothelioma: mythe or hype?
Harvey Pass, New York University, USA
13.05
Summary
Jan van Meerbeeck, UAntwerpen
13.10 Walking lunch
Auteur
Document
Catégorie
Uncategorized
Affichages
4
Taille du fichier
429 KB
Étiquettes
1/--Pages
signaler